{"id":"W3042050487","doi":"10.1038/s41531-020-0117-1","title":"Current and projected future economic burden of Parkinson’s disease in the U.S.","year":2020,"lang":"en","type":"article","venue":"npj Parkinson s Disease","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":636,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Neurological Disorders and Stroke; Perelman School of Medicine, University of Pennsylvania; Adamas Pharmaceuticals; ACADIA Pharmaceuticals; Acorda Therapeutics; Parkinson's Foundation; Michael J. Fox Foundation for Parkinson's Research; American Parkinson Disease Association; AbbVie; University of Toronto; Biogen; University of Pennsylvania; Parkinson Alliance","keywords":"Parkinson's disease; Disease; Medicine; Gerontology; Psychology; Psychiatry; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02176276868332302,"score_gpt":0.2740912357480085,"score_spread":0.2523284670646855,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}